MIMS often provides than CIMS and some government formularies, particularly for safety information (contraindications, warnings, adverse effects). However, it is a commercial publication, so its coverage may favour products that are actively marketed in primary care, whereas a national formulary may be more comprehensive for hospital‑only or less profitable drugs.
First published in 1959, MIMS is a comprehensive pharmaceutical database that offers concise drug monographs. Each entry typically includes:
Your , as drug availability and MIMS versions vary heavily by country.
MIMS is highly localized. Using a PDF meant for India while practicing in the UK can lead to prescribing errors due to differing brand names and regulatory approvals. monthly index of medical specialities pdf
The first MIMS publication appeared in the UK in at a time when the pharmaceutical landscape was far less complex. From fewer than 2,000 drugs in that inaugural edition, MIMS has grown to provide concise listings for more than 3,000 products. For many years the print edition was issued quarterly and distributed freely to all practice‑based GPs, with paid subscriptions available to other professionals. In 2023, the December print issue marked the final quarterly print edition, as the publication moved primarily online, though PDF‑based versions continue to be used by many subscribers.
Some versions allow clinicians to scan a drug's packaging barcode to instantly pull up its digital monograph. 3. Electronic Health Record (EHR) Integration
Essential for avoiding "double-prescribing." Indications: What the drug is actually approved to treat. MIMS often provides than CIMS and some government
While the PDF remains a staple for many practitioners due to its familiarity and offline utility, the trajectory of MIMS points toward deeper integration. The current trend is moving away from static documents (PDFs) toward Application Programming Interfaces (APIs).
I can guide you to the safest, most efficient way to access authorized drug directories. Share public link
In certain countries, membership in the national medical or pharmaceutical association includes a complimentary subscription to the digital MIMS database. Conclusion Each entry typically includes: Your , as drug
: Clinical protocols and essential medicine lists, such as the AIIMS Rishikesh Guidelines .
Clear cross-referencing between active ingredients and commercial trade names.
Although MIMS is increasingly distributed online, for several reasons. A PDF version of MIMS can be downloaded onto a laptop, tablet, or smartphone and used without an internet connection. Healthcare professionals who work in remote clinics, during flights, or in areas with unreliable internet find PDF editions invaluable.
| Feature | Description | |---------|-------------| | Target audience | GPs, pharmacists, hospital clinicians, nurses, and other healthcare professionals | | Typical format | Print volumes, PDF editions, mobile apps, and an online database | | Update frequency | Print/PDF editions issued quarterly or monthly; online version updated constantly | | Key content | Concise monographs, drug comparison tables, national treatment guidelines, visual guides, price trackers | | Geographic reach | Editions available for over 15 countries/regions worldwide |